---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-114448"
form_type: "8-K"
ticker: "SEM"
cik: "0001320414"
company_name: "SELECT MEDICAL HOLDINGS CORP"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T08:18:21.576880+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Select Medical Q3 net income drops 62% to $38.1M; EPS $0.21 vs $0.57

## Summary
- Revenue $1,567.8M (+2.2% YoY); net income $38.1M vs $100.2M; EPS $0.21 vs $0.57.
- Adjusted EBITDA fell to $153.1M from $208.6M; operating income $91.5M vs $150.3M.
- Critical illness recovery hospital segment Adjusted EBITDA plunged to $11.0M from $57.2M; margin 2.1% vs 10.8%.
- Board declared $0.125 per share dividend, payable Nov 29 to holders of record Nov 16.
- Reaffirmed FY2022 revenue outlook of $6.25-6.40B; labor climate delays EBITDA and EPS guidance.

## SEC filing metadata
- accession: 0001104659-22-114448
- form_type: 8-K
- ticker: SEM
- cik: 0001320414
- company_name: SELECT MEDICAL HOLDINGS CORP
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1320414/000110465922114448/0001104659-22-114448-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1320414/000110465922114448/tm2229569d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-114448
- JSON: https://secwatch.observer/filing/0001104659-22-114448.json
- Plain text: https://secwatch.observer/filing/0001104659-22-114448.txt

## Key facts
- Earnings Releases
  SELECT MEDICAL HOLDINGS CORP reported nine months ended September 30, 2022 results: revenue $4,752.1 million, net income $160.3 million, EPS $1.01.
  - Period: nine months ended September 30, 2022
  - Revenue: $4,752.1 million
  - Net income: $160.3 million
  - EPS: $1.01
  - Result: reported results
  source text: For the nine months ended September 30, 2022, revenue increased 2.3% to $4,752.1 million, compared to $4,644.7 million for the same period, prior year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1320414/000110465922114448/0001104659-22-114448-index.htm
- Earnings Releases
  SELECT MEDICAL HOLDINGS CORP reported third quarter ended September 30, 2022 results: revenue $1,567.8 million, net income $38.1 million, EPS $0.21.
  - Period: third quarter ended September 30, 2022
  - Revenue: $1,567.8 million
  - Net income: $38.1 million
  - EPS: $0.21
  - Result: reported results
  source text: Select Medical Holdings Corporation (“Select Medical,” “we,” “us,” or “our”) (NYSE: SEM) today announced results for its third quarter ended September 30, 2022, and the declaration of a cash dividend. For the third quarter ended September 30, 2022, revenue increased 2.2% to $1,567.8 million, compared to $1,534.2 million for the same quarter, prior year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1320414/000110465922114448/0001104659-22-114448-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.